Category: Insights

The complex treatment process of CAR T therapies requires a life sciences commercial teams to take a unique approach to product launches. In Med Ad News, Dennis Fournogerakis and Nathaniel Swenson describe the strategic approach commercial teams should take to ensure innovative, new CAR T treatments quickly reach patients in need.

By unbundling technology infrastructure and governance (through a protocol layer like blockchain), Web3 promises to usher in a shift away from tech monopolies and a winner-takes-all competitive landscape. In Pharmaceutical Executive, Rohit Gupta discusses how biopharma companies can put themselves in position to capitalize as Web3 matures and its impact is more fully realized across health care.

To unlock the full potential of emerging next-gen patient support tools, pharmaceutical companies must recognize the crucial role advanced analytics plays in facilitating enhanced patient engagement that yields improved adherence. David Laros describes the keys to success in Pharmaceutical Commerce.

To become more customer-centric, pharmaceutical companies should reassess their commercial operations and marry meaningful organizational change with new, overarching technology infrastructures. In PM360, David Laros and Robert Lien present a three-pronged approach to help companies embed customer centricity into their commercial operations at launch.

In Med Ad News’ Agenda 2022 feature, Kevin Frymire comments on how pharma sales forces can improve effectiveness in the year ahead, and Robert Lien discusses how technology can support companies’ efforts to become more customer centric.

Oracle’s acquisition of Cerner is the latest attempt by Big Tech to make waves in the health care industry. The deal has the potential to impact the user experience of health care professionals and facilitate improved data analysis of electronic health records, though obstacles still remain for widespread data exchange. Rohit Gupta explores potential impacts of the deal in Pharmaceutical Executive.

As big tech’s health care disruption efforts flag, biopharma companies can step up to empower patients and improve care, Rohit Gupta writes in Pharmaceutical Executive.

With data proliferating rapidly in the biopharma industry, it’s crucial that commercial teams bring disjointed data together into holistic data sets. In Med Ad News, Justin Khalifa presents four keys to success.

COVID-19 has kept medical science liaisons grounded for more than a year. In response, they’ve been busy mastering the art of the digital connection to continue delivering crucial scientific information to healthcare practitioners and key opinion leaders. In PharmaVOICE, Rohit Gupta discusses the changing role of medical science liaisons as a result of the COVID-19 pandemic.